Digital Medicine for Inflammatory Bowel Disease

Recruiting in Palo Alto (17 mi)

+5 other locations

Overseen byAshish Atreja, MD, MPH

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Icahn School of Medicine at Mount Sinai

No Placebo Group

Trial Summary

What is the purpose of this trial?This trial aims to use digital tools like apps and remote monitoring to help people with Inflammatory Bowel Disease (IBD). By integrating these tools into a unified system connected to electronic health records, the study hopes to improve disease management and reduce emergency visits. The goal is to see if these digital methods can be widely adopted and benefit patients' health.

Eligibility Criteria

This trial is for adults over 18 with Inflammatory Bowel Disease (IBD) who can communicate in English or Spanish. It's not suitable for individuals with conditions like advanced dementia that would make using digital tools extremely challenging.

Inclusion Criteria

I have been diagnosed with Inflammatory Bowel Disease.

Ability to speak or understand English or Spanish Language.

I am 18 years old or older.

Exclusion Criteria

Condition or disease that, in the opinion of the investigators, may make it exceedingly difficult for the patient to use DTN, including, but not limited to, advanced dementia.

Participant Groups

The study is testing a Digital Transformation Network (DTN) Program designed to integrate digital medicine into everyday healthcare for IBD patients, aiming to improve care outside of traditional clinical settings.

2Treatment groups

Experimental Treatment

Active Control

Group I: Digital Transformation Network (DTN) ProgramExperimental Treatment1 Intervention

IBD patients at the 3 sites will be sent a message to their Smartphone

Group II: Control ArmActive Control1 Intervention

Patients will enter the control group once they initially complete the ePRO and online assessment tools. They will remain in the control group, and then at set intervals each site will transition these patients into the DTN intervention arm.